More than two dozen state attorneys general are objecting to part of a possible deal between the federal government and Purdue Pharma that would resolve alleged criminal and civil charges over the company’s role in fueling the opioid crisis.
Specifically, the state officials are upset that the drug maker would be transformed into a public benefit company and run on behalf of the numerous communities around the U.S. that have been pursuing Purdue for compensation. A report earlier this month by Reuters indicated the Department of Justice is considering such a move as part of a broader settlement that could be announced as soon as this month.
About the Author Reprints
